###### 

Patient characteristics

                                       IDUs (N = 91)         Sexually infected (N = 154)   p value, OR (95% CI)
  ------------------------------------ --------------------- ----------------------------- ------------------------------
  Male N (%)                           73 (80)               101 (66)                      0.015, 0.4 (0.2--0.8)
  Age (years) (median, IQR)            30 (IQR: 26--34)      34 (IQR: 26--41)              \<0.001
  CD4 (cells/mm^3^) (median, IQR)      350 (IQR: 154--600)   272 (IQR: 91--405)            \<0.001
  Late presenters (CD4 \< 350) N (%)   45 (50)               102 (66)                      0.01, 1.3 (1.0--1.7)
  Stage A N (%)                        60 (66)               60 (39)                       \<0.001, 3.0 (1.7--5.2)
  Stage B N (%)                        21 (23)               53 (34)                       0.062, 0.5 (0.3--1.03)
  Stage C N (%)                        10 (11)               41 (27)                       0.004, 2.4 (1.2--4.6)
  Hepatitis C N (%)                    84 (92)               8 (5)                         \<0.001, 255.5 (85.7--761.4)
  Hepatitis B N (%)                    12 (13)               19 (12)                       0.822, 1.09 (0.5--2.3)
  Syphilis N (%)                       4 (4)                 26 (17)                       0.006, 3.6 (1.3--10.0)
  Tuberculosis N (%)                   1 (1)                 13 (8)                        0.064, 0.1 (0.07--1.3)
  Pneumocystosis N (%)                 2 (2)                 7 (5)                         0.709, 0.7 (0.1--4.2)

IQR = interquartile range, IDUs = injecting drug users.
